Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Unsuitable test system (IHT with solid).

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
yes
Remarks:
(exposure for 8 hours, no analytics of distribution, 7 day observation period)
Principles of method if other than guideline:
BASF test (IHT):
The test demonstrates the toxicity of an atmosphere enriched with dust of the test substance at room temperature. Young adult laboratory rats, 6 per sex, were exposed sequentially to the dust generated by bubbling 200 L/h air through a substance column of about 5 cm above a fritted glass disc in a glass cylinder for 8 h. The nominal concentration was calculated as quotient of the amount of test substance weight loss during exposure, and the amount of air used during exposure. Group-wise documentation of clinical signs was performed over a 7 day study period. Body weight of groups was determined before the start of the study and at the end of the observation period.
GLP compliance:
no
Test type:
other: Inhalation hazard test (IHT)
Limit test:
yes

Test material

Constituent 1
Reference substance name:
[N,N,N',N',N'',N''-hexaethyl-29H,31H-phthalocyaninetrimethylaminato(2-)-N29,N30,N31,N32]copper tris(dodecylbenzenesulphonate)
EC Number:
278-150-3
EC Name:
[N,N,N',N',N'',N''-hexaethyl-29H,31H-phthalocyaninetrimethylaminato(2-)-N29,N30,N31,N32]copper tris(dodecylbenzenesulphonate)
Cas Number:
75247-18-6
Molecular formula:
C47 H49 Cu N11 .3 C18 H30 O3 S
IUPAC Name:
Copper,N,N,N',N',N'',N''-hexaethyl-29H,31H-phthalocyanine-C,C,C-trimethanaminato(2-)-κN29,κN30,κN31,κN32]-,dodecylbenzenesulfonate (1:3)
Details on test material:
Please refer to chapter confidential details on test material

Test animals

Species:
rat
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 193 g (mean)

ENVIRONMENTAL CONDITIONS: not reported

Administration / exposure

Route of administration:
inhalation: dust
Type of inhalation exposure:
whole body
Vehicle:
air
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Source and rate of air: No source mentioned; 200 L/h
- Temperature in air chamber: 20°C
- System of generating particulates/aerosols: bubbling 200 L/h air through a substance column

TEST ATMOSPHERE
- Brief description of analytical method used: reweighing of a substance column
- Samples taken from breathing zone: no

VEHICLE:
- composition of vehicle
- concentration of test material in vehicle: 13.35 mg/L (nominal concentration)



Analytical verification of test atmosphere concentrations:
no
Duration of exposure:
8 h
Concentrations:
13.35 mg/L (mean) (Nominal concentration was calculated as quotient of the amount of test substance weight loss during the exposure and the amount of air used during the exposure)
No. of animals per sex per dose:
6 rats
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 7 days
Statistics:
not performed

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LC0
Effect level:
13 mg/L air (nominal)
Exp. duration:
8 h
Remarks on result:
other: No animals died. No clinical signs were observed.
Mortality:
No mortality was observed
Clinical signs:
other: No clinical signs were observed.
Gross pathology:
No findings.

Any other information on results incl. tables

A strong dust formation was observed.

Applicant's summary and conclusion